Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 27 studies | 48% ± 13% | |
germinal center B cell | 4 studies | 59% ± 14% | |
brush cell | 4 studies | 49% ± 26% | |
B cell | 3 studies | 61% ± 19% |
Insufficient scRNA-seq data for expression of RGS13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 180.54 | 574 / 578 | 14% | 0.43 | 167 / 1155 |
stomach | 95% | 68.72 | 342 / 359 | 7% | 3.66 | 21 / 286 |
bladder | 95% | 109.90 | 20 / 21 | 7% | 0.24 | 35 / 504 |
prostate | 95% | 104.33 | 232 / 245 | 4% | 0.14 | 19 / 502 |
esophagus | 89% | 105.52 | 1291 / 1445 | 7% | 0.16 | 13 / 183 |
intestine | 87% | 131.77 | 840 / 966 | 9% | 0.89 | 50 / 527 |
adipose | 92% | 83.52 | 1105 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 56.83 | 26 / 29 |
breast | 80% | 45.47 | 365 / 459 | 8% | 0.33 | 95 / 1118 |
uterus | 79% | 53.86 | 135 / 170 | 2% | 0.08 | 11 / 459 |
skin | 65% | 55.79 | 1172 / 1809 | 9% | 0.41 | 43 / 472 |
pancreas | 39% | 10.81 | 128 / 328 | 32% | 1.13 | 57 / 178 |
spleen | 62% | 32.35 | 149 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 49% | 21.10 | 655 / 1335 | 0% | 0 | 0 / 0 |
thymus | 18% | 21.90 | 115 / 653 | 6% | 0.45 | 37 / 605 |
peripheral blood | 22% | 32.93 | 207 / 929 | 0% | 0 | 0 / 0 |
kidney | 18% | 11.10 | 16 / 89 | 3% | 0.04 | 26 / 901 |
heart | 20% | 5.44 | 176 / 861 | 0% | 0 | 0 / 0 |
liver | 10% | 2.18 | 23 / 226 | 3% | 0.12 | 13 / 406 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.33 | 5 / 45 |
muscle | 11% | 3.01 | 89 / 803 | 0% | 0 | 0 / 0 |
ovary | 11% | 2.88 | 19 / 180 | 0% | 0 | 0 / 430 |
brain | 7% | 2.08 | 183 / 2642 | 0% | 0.09 | 3 / 705 |
adrenal gland | 3% | 0.56 | 7 / 258 | 1% | 0.05 | 2 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045744 | Biological process | negative regulation of G protein-coupled receptor signaling pathway |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RGS13 |
Protein name | Regulator of G-protein signaling 13 (RGS13) |
Synonyms | |
Description | FUNCTION: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to both G(i)-alpha and G(q)-alpha (By similarity). . |
Accessions | ENST00000391995.7 ENST00000543215.5 O14921 |